Skinny, thanks I've changed it to read "...below 25p"
Currently, though I doubt LLOY will reach 38p even if the UK Gov sells their lot; so I've left that "38p" as was.
I expect that your expectation soon will be a goodly rise = when dividends get sensible - although that's my wish too, I do wonder that the Execs are rather timid . . . holding AGM's in Edinburgh where they get a big cheer from the HBOS tribes. Also, without the profitable PPI, I wonder that alternative "Branch-less" Banks won't be able to offer better Interest and therefore cheaper Mortgages ( which was said to be the main reason for snapping-up HBOS ).
If the yield rises to 2%, then yr equiv from 21p will approach 8% - so that's well done, although it's a pity abt. the lengthy delay.
EDIT (16Jan2016)- 64p after a bit of a shock, but then many sectors are being hit by Crude Oil's falling to USD25 - maybe we should buy some to keep for a cold snap....Brr!

Am hoping this is the bottom of this particular drop.

If it isn't I shall eat my hat. It is probably just as well that I do not have one though!

From 47 seconds...

What's upset Lloyds ,i hope it's not a stupid broker rec ..

13 Jan Exane BNP... 74.00 Underperform
11 Jan Deutsche Bank 91.00 Buy
11 Jan Barclays... 95.00 Overweight

Like this one.....

Exane BNP Paribas Underperform 68.61 - 74.00 Downgrades

That's the second downgrade in five months from BNP, Stan may have to eat a bit more of Ollie's hat!

66p!!!!! What the hell is going on? :o(

Hmmm.........62p support?

Hard to believe that one broker note can do the damage, but seems Exane have done just that!

"We expect another disappointing year for UK banks. Our thoughts have developed a little since the publication of our last sector thematic, UK BANKS: Nowhere to hide, September 2015, but our fundamental concerns are the same.
1) The capital debate has progressed, with recent developments fairly positive for UK banks, but we still believe dividend distributions will disappoint. This is particularly the case for Barclays and LBG – indeed, we increasingly believe that the former should raise capital in 2016.
2) The operational outlook for banks remains bleak. This year we expect margins to decline, potentially appreciably, as a function of weaker asset yields, lower contributions from structural hedges, and the potential re-emergence of deposit competition. We also expect to see cost disappointment at certain banks. And unlike last year, weakness in pre-provision profit is unlikely to be rescued by lower impairment charges, with releases and recoveries starting to fall away.
While it is hard to argue that the sector is expensive, particularly following recent share price falls, the combination of continued dividend disappointment, capital uncertainty, and further disappointment on earnings, leads us to remain cautious.
RBS (Outperform). We believe the shares are cheap at current levels and provide considerable asymmetric risk for investors. However, we think performance will take time to emerge, with the key catalyst remaining a settlement relating to US RMBS.
HSBC (Neutral). Recent pronouncements on capital give credence to the idea that dividends are sustainable and at the current yield this provides downside support to the shares. Higher US interest rates should also eventually be supportive to margin but overall we think upside is limited.
Barclays (Underperform). We believe the bank is light on capital and the lack of action to address this is leading to lost opportunities to generate value and earnings accretion in the core businesses. A clear intent by Barclays to fix its capital position would likely lead us to upgrade our rating. But for now, we think capital concerns will linger and act as a drag on relative performance
LBG (Underperform). We believe dividend distributions and buybacks will disappoint. Furthermore, margin pressure will build as 2016 progresses, the bank is likely to miss its cost target, and impairments could begin to rise as releases and recoveries fall away.
Standard Chartered (Underperform). While superficially cheap, considerable risk remains around impairments which could eventually put capital under further pressure. We also expect revenues to disappoint and miss management targets – with ROTE not
reaching the COE for at least five years."

Hard to believe that one broker note can do the damage, but seems Exane have done just that!
---------------------------

Yes HARRY the other broker rec's don't seem to matter ...

13 Jan Exane BNP... 215.00 Underperform
12 Jan JP Morgan... 290.00 Overweight
11 Jan Deutsche Bank 303.00 Buy
----------------------------------------------------------

13 Jan Exane BNP... 74.00 Underperform
11 Jan Deutsche Bank 91.00 Buy
11 Jan Barclays... 95.00 Overweight

As we know they only need one excuse boys.

Bought back into LLOY
2517

Yes, I am watching as well, but still think there is more downside to come.

You are probably right HARRYCAT, especially now I'm back in. I like LVD, UEM plus 3 or 4 others that I will pick up over the coming weeks. On a 2 or 3 year view this is a buying opportunity imo if you can stomach the gyrations.
2517

64p....still a little more to go, imo.

.

lots of stocks are starting to look exceptional value, but if one accepts the caveat that what is cheap today may be cheaper tomorrow, then there may soon be a case for dipping one's toes back in the markets ...... but not today i think

Will certainly have a dabble here if it hits 62p.

How about 30p